Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Octapharma Limited, The Zenith Building, 26 Spring Gardens, Manchester, M2 1AB
OctaplasLG, solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. The frozen solution is (slightly) yellow. |
A 200 ml bag contains 9-14 g of ABO-blood group specific human plasma proteins (45-70 mg/mL). octaplasLG is supplied in separate presentations according to the following blood groups:
Blood group A
Blood group B
Blood group AB
Blood group O
For details about important coagulation factors and inhibitors, see section 5.1 and table 2.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Human plasma protein fraction |
|
| List of Excipients |
|---|
|
Sodium citrate dihydrate |
200 ml of ABO-blood group specific human plasma proteins in bag (polyvinyl chloride) over-wrapped with a film.
Pack size of 1 and 10.
Octapharma Limited, The Zenith Building, 26 Spring Gardens, Manchester, M2 1AB
PL 10673/0009
04/03/2008
| Drug | Countries | |
|---|---|---|
| OCTAPLASLG | Ecuador, Estonia, Finland, France, Croatia, Malta, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
